CONGRESS: 22–25 SEPTEMBER 2025
immunochemistry and has authored and co-authored several peer-reviewed publications in the discipline.
Cytopathology UK NEQAS for Reproductive Science is operated by the Manchester University NHS Foundation Trust, from the Trust’s reproductive science department, illustrating again how UK NEQAS participants benefit from EQA directed by experts in their fields. Tamanda Timvere Hartley will highlight emerging research and potential strategies for improving male reproductive health as part of the Cytopathology programme at Congress. Tamanda will give an overview of male fertility, including current sperm assessment techniques.
As well as its involvement in the scientific programme, UK NEQAS will be exhibiting throughout the event at stand R15 in the registration area.
WHO and ICC classification systems for haematological malignancy (Nicki Lawrence and Professor Barbara Bain).
Immunology
Looking at the Immunology sessions, we see that Deborah Pritchard, Head of Transplantation Service at the Welsh Blood Service, is talking both on the introduction of cff DNA testing and regulatory lymphocytes in transplantation. Deborah’s portfolio includes the Welsh Bone Marrow Donor Registry, which recruits volunteer donors and collects stem cells from matched donors for patients in need of a stem cell transplant. Although these talks are not on EQA, Deb is the Director of the worldwide UK NEQAS for Histocompatibility & Immunogenetics (H&I), illustrating how UK NEQAS benefits from the direction of recognised scientists in their fields who operate UK NEQAS Schemes alongside their substantive roles. Staying with Immunology, Amy De’Ath, who is a senior member of staff in Transplantation Services at the Welsh Blood Service and another member of the UK NEQAS H&I centre, will present a joint UK NEQAS and British Society for Histocompatibility and Immunogenetics (BSHI) guideline on the laboratory testing and clinical interpretation of HLA genotyping results supporting the diagnosis of coeliac disease. Amy will explain why UK NEQAS for H&I created a test of guidelines to inform the genetic testing for this disease, supported by the collaboration in EQA services. Amy
62
plays an active role in training and development within the transplantation community, serving on both the BSHI Research Executive and Education Board. Dina Patel and Carol Stanley from UK NEQAS Immunology, Immunochemistry and Allergy (IIA) will share fresh perspectives on how EQA data informs practice in the monitoring of anti– tumour necrosis factor (TNF) drugs and antibodies. Dina Patel returns to the Immunology programme on Thursday 25th, turning her focus to anti-nuclear antibody (ANA) testing, examining current laboratory practice and the growing impact of the International Consensus on Antinuclear Antibody Patterns (ICAP) nomenclature. Drawing on EQA findings, she will highlight the variation in ANA testing observed across laboratories and discuss how ICAP has helped to drive harmonisation within the field. By identifying variation in methods and results, EQA schemes provide a platform for education, dialogue with manufacturers, and collaboration with professional bodies – all of which contribute to raising standards and improving outcomes for patients. As Scientific Director, Dina Patel spearheads UK NEQAS IIA’s efforts in global EQA leadership. Her responsibilities range from delivering interpretative advice and troubleshooting assay performance to representing the organisation in national and international advisory and educational forums. Alongside these duties, she leads scientific and technical research in immunology and
Exhibition and posters Throughout Congress, UK NEQAS will be based at Stand R15, where representatives from across all disciplines will be available to meet delegates. Whether you have a specific query about our services or simply want to connect with the team, our staff will be on hand to help – or to arrange a time for you to speak with the right specialist. The majority of IBMS delegates will be very familiar with UK NEQAS services but the Congress gives us the opportunity to strengthen connections with our valued participants. In addition, we will be inviting feedback through a ‘praise and grumble’ box, offering delegates the chance to share their thoughts – anonymously if preferred – on our services. Proud of our position as world leader in External Quality Assessment services, UK NEQAS continues to deliver a unique blend of expertise, independence, and international benchmarking. Working with us, you benefit from our unique approach and expertise, knowing that you are being compared to the best by the best, throughout the world. Finally, apologies to any of our colleagues we have missed and, of course, don’t forget there will be UK NEQAS posters too!
Acknowledgements n With thanks to Jen Christie and Leah
Edwards from the UK NEQAS Central Office.
Barbara De la Salle is UK NEQAS President Dina Patel is Scientific Director at UK NEQAS IIA
www.ukneqas.org.uk
For the full Congress programme visit the website.
www.congress.ibms.org/
SEPTEMBER 2025
WWW.PATHOLOGYINPRACTICE.COM
Page 1 |
Page 2 |
Page 3 |
Page 4 |
Page 5 |
Page 6 |
Page 7 |
Page 8 |
Page 9 |
Page 10 |
Page 11 |
Page 12 |
Page 13 |
Page 14 |
Page 15 |
Page 16 |
Page 17 |
Page 18 |
Page 19 |
Page 20 |
Page 21 |
Page 22 |
Page 23 |
Page 24 |
Page 25 |
Page 26 |
Page 27 |
Page 28 |
Page 29 |
Page 30 |
Page 31 |
Page 32 |
Page 33 |
Page 34 |
Page 35 |
Page 36 |
Page 37 |
Page 38 |
Page 39 |
Page 40 |
Page 41 |
Page 42 |
Page 43 |
Page 44 |
Page 45 |
Page 46 |
Page 47 |
Page 48 |
Page 49 |
Page 50 |
Page 51 |
Page 52 |
Page 53 |
Page 54 |
Page 55 |
Page 56 |
Page 57 |
Page 58 |
Page 59 |
Page 60 |
Page 61 |
Page 62 |
Page 63 |
Page 64 |
Page 65 |
Page 66 |
Page 67 |
Page 68 |
Page 69 |
Page 70 |
Page 71 |
Page 72 |
Page 73 |
Page 74 |
Page 75 |
Page 76 |
Page 77 |
Page 78 |
Page 79 |
Page 80 |
Page 81 |
Page 82 |
Page 83 |
Page 84
